PwC is pleased to have advised Sigma Pharmaceuticals Plc, one of the UK’s largest independent short-line pharmacy wholesalers, in securing an increased asset-based lending facility of £50m provided by Leumi ABL. The new facility will provide Sigma with the financial flexibility to further strengthen its market position and capitalise on opportunities in the evolving UK pharmacy sector, underpinning its next phase of growth.
Founded in 1982, Sigma Pharmaceuticals has established itself as a critical partner to over 2,000 independent and regional chain pharmacies across the UK, supplying a comprehensive portfolio of over 4,500 product lines including generics, over-the-counter medicines, ethical products, and specialist items. Sigma’s robust business model is underpinned by a diversified customer base, strong supplier relationships, and a reputation for service excellence and regulatory compliance.
The refinancing comes at a pivotal time for Sigma, as the UK pharmacy market continues to see a marked shift towards independent operators. Sigma’s focus on this dynamic segment means it is well positioned to benefit from changes in consumer preferences.
The new asset-based lending facility provides a strong financial foundation that allows the business to continue to support its core customer base of independent and regional chain pharmacies as well as investing in operational efficiencies and pursing strategic opportunities.
“This refinance marks a significant milestone for the Sigma Pharmaceuticals group, positioning us for a new phase of strategic growth and expansion. We are confident that this new facility will provide the flexibility and capital needed to achieve our long-term goals.”
PwC’s Debt & Capital Advisory team advised on the deal, led by Chris Hawes, with support from Emma Lister, Richard Davies, Pavan Mohan and Shonalee Maurya.
“We are delighted to have supported Sigma Pharmaceuticals in securing this new facility. The transaction highlights the critical role of asset-based lending in providing flexible, scalable funding solutions for businesses at the heart of the UK’s healthcare supply chain. Sigma’s strong market fundamentals and commitment to operational excellence make it an exciting business for the future.”
Victoria Baker and Adam Patel at Pinsent Masons provided legal advice for Sigma. DLA provided legal advice for Leumi ABL.
Contact us
